Pharmacogenomics, the application of genotyping to patient therapy, holds great promise for solving a long-standing problem: differences in individual responses to drug treatments. The ultimate goal is to maximize drug efficacy while minimizing side effects. The time when a report with each person's genetic code will guide doctors in personalized medicine is still far away, but pharmacogenomics already is allowing physicians to make treatment decisions regarding human immunodeficiency virus type 1 (HIV-1).
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?